PhaseRx
Seattle, US · Delaware corporation · 1 known investors
Founders & leadership
RW
ROBERT W. OVERELLFounder
PJ
PAUL JOHNSONExecutive
MH
Michael HoustonExecutive
AL
Andrew LeonExecutive
RW
Robert W. OverellExecutive
PH
Paul H. JohnsonExecutive
Board
JS
JOHN SCHMIDTBoard director
BA
BRIAN ATWOODBoard director
SG
STEVEN GILLISBoard director
SG
Steven GillisBoard director
JD
John D. DiekmanBoard director
JA
John A. SchmidtBoard director
Investors · 1
Reported raises · per SEC filings
Form D private placements$7.6M disclosed across 2 of 3 rounds · 2012–2016
▶$420KofferedJun 2016 · 1 investors · BiotechnologyRule 506(b)
▶$420KofferedJun 2016 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- PAUL JOHNSONExecutive Officer, Director
- Michael HoustonExecutive Officer
- Shing-Yin (Helen) TsuiExecutive Officer
- JOHN SCHMIDTDirector
- ROBERT W. OVERELLExecutive Officer, Director, Promoter
- BRIAN ATWOODDirector
- Richard UlevitchDirector
- Michelle GriffinDirector
- STEVEN GILLISDirector
- Offering amount
- $420K
- First sale
- Jun 2016
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$4MraisedDec 2015 · 17 investors · BiotechnologyRule 506(b)
▶$4MraisedDec 2015 · 17 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- JOHN SCHMIDTDirector
- Richard UlevitchDirector
- ROBERT W. OVERELLExecutive Officer, Director, Promoter
- PAUL JOHNSONExecutive Officer, Director
- BRIAN ATWOODDirector
- STEVEN GILLISDirector
- Michael HoustonExecutive Officer
- Offering amount
- $4M
- Amount sold
- $4M
- Sales commissions
- $280K
- Placement agents
- Palladium Capital Advisors, LLC
- First sale
- Dec 2015
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$3.6MraisedFeb 2012 · 5 investors · BiotechnologyRule 506(b)
▶$3.6MraisedFeb 2012 · 5 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Andrew LeonExecutive Officer
- Steven GillisDirector
- John D. DiekmanDirector
- John A. SchmidtDirector
- Brian G. AtwoodDirector
- Robert W. OverellExecutive Officer, Director, Promoter
- Paul H. JohnsonExecutive Officer, Director
- Offering amount
- $4.7M
- Amount sold
- $3.6M
- First sale
- Feb 2012
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Frequently asked questions
- Who founded PhaseRx?
- PhaseRx was founded by ROBERT W. OVERELL.
- Who are PhaseRx's investors?
- PhaseRx's investors include 5AM Ventures.
- How much funding has PhaseRx raised?
- PhaseRx has disclosed $7.6M raised across 2 of its 3 known rounds.
- Where is PhaseRx headquartered?
- PhaseRx is headquartered in Seattle, US.